443 related articles for article (PubMed ID: 33569055)
21. Ocular immune privilege in the year 2010: ocular immune privilege and uveitis.
Taylor AW; Kaplan HJ
Ocul Immunol Inflamm; 2010 Dec; 18(6):488-92. PubMed ID: 21091058
[TBL] [Abstract][Full Text] [Related]
22. Resolution of uveitis.
Wildner G; Diedrichs-Möhring M
Semin Immunopathol; 2019 Nov; 41(6):727-736. PubMed ID: 31591678
[TBL] [Abstract][Full Text] [Related]
23. [Significance of autoimmunity in various forms of uveitis].
Zierhut M; Klein R; Berg P; Thiel HJ
Klin Monbl Augenheilkd; 1991 Mar; 198(3):165-73. PubMed ID: 1829128
[TBL] [Abstract][Full Text] [Related]
24. Gut microbiota as a source of a surrogate antigen that triggers autoimmunity in an immune privileged site.
Zárate-Bladés CR; Horai R; Mattapallil MJ; Ajami NJ; Wong M; Petrosino JF; Itoh K; Chan CC; Caspi RR
Gut Microbes; 2017 Jan; 8(1):59-66. PubMed ID: 28045579
[TBL] [Abstract][Full Text] [Related]
25. The Role of Gut Microbiome in Autoimmune Uveitis.
Fu X; Chen Y; Chen D
Ophthalmic Res; 2021; 64(2):168-177. PubMed ID: 32674100
[TBL] [Abstract][Full Text] [Related]
26. Mechanisms of blood-retinal barrier disruption related to intraocular inflammation and malignancy.
Tomkins-Netzer O; Niederer R; Greenwood J; Fabian ID; Serlin Y; Friedman A; Lightman S
Prog Retin Eye Res; 2024 Mar; 99():101245. PubMed ID: 38242492
[TBL] [Abstract][Full Text] [Related]
27. The role of uveal and retinal antigens in experimental autoimmune ocular pathology.
Wacker WB; Kalsow CM
Mod Probl Ophthalmol; 1976; 16():12-20. PubMed ID: 765778
[TBL] [Abstract][Full Text] [Related]
28. Localization and characterization of major histocompatibility complex class II-positive cells in the posterior segment of the eye: implications for induction of autoimmune uveoretinitis.
Forrester JV; McMenamin PG; Holthouse I; Lumsden L; Liversidge J
Invest Ophthalmol Vis Sci; 1994 Jan; 35(1):64-77. PubMed ID: 8300365
[TBL] [Abstract][Full Text] [Related]
29. New developments in uveitis associated with HLA B27.
Rosenbaum JT
Curr Opin Rheumatol; 2017 Jul; 29(4):298-303. PubMed ID: 28376061
[TBL] [Abstract][Full Text] [Related]
30. Disruption of Intestinal Homeostasis and Intestinal Microbiota During Experimental Autoimmune Uveitis.
Janowitz C; Nakamura YK; Metea C; Gligor A; Yu W; Karstens L; Rosenbaum JT; Asquith M; Lin P
Invest Ophthalmol Vis Sci; 2019 Jan; 60(1):420-429. PubMed ID: 30695094
[TBL] [Abstract][Full Text] [Related]
31. Proposed immune mechanisms in uveitis and their modulation.
Nussenblatt RB; Palestine AG; Chan CC
Int Ophthalmol Clin; 1985; 25(2):81-93. PubMed ID: 3159706
[No Abstract] [Full Text] [Related]
32. A20 Inhibits Intraocular Inflammation in Mice by Regulating the Function of CD4+T Cells and RPE Cells.
Hu J; Yi S; Wang C; Zhang Y; Tang J; Huang X; Yang L; Yang J; Li H
Front Immunol; 2020; 11():603939. PubMed ID: 33613524
[TBL] [Abstract][Full Text] [Related]
33. Ocular immune privilege and retinal pigment epithelial cells.
Du Y; Yan B
J Leukoc Biol; 2023 Mar; 113(3):288-304. PubMed ID: 36805720
[TBL] [Abstract][Full Text] [Related]
34. Kallistatin Attenuates Experimental Autoimmune Uveitis by Inhibiting Activation of T Cells.
Muhammad F; Avalos PN; Mursalin MH; Ma JX; Callegan MC; Lee DJ
Front Immunol; 2020; 11():975. PubMed ID: 32508841
[TBL] [Abstract][Full Text] [Related]
35. Organ-specific protection mediated by cooperation between vascular and epithelial barriers.
Spadoni I; Fornasa G; Rescigno M
Nat Rev Immunol; 2017 Dec; 17(12):761-773. PubMed ID: 28869253
[TBL] [Abstract][Full Text] [Related]
36. Diagnosis and classification of autoimmune uveitis.
Selmi C
Autoimmun Rev; 2014; 13(4-5):591-4. PubMed ID: 24424168
[TBL] [Abstract][Full Text] [Related]
37. Uveitis: Molecular Pathogenesis and Emerging Therapies.
Egwuagu CE; Alhakeem SA; Mbanefo EC
Front Immunol; 2021; 12():623725. PubMed ID: 33995347
[TBL] [Abstract][Full Text] [Related]
38. ICAM-1 and VCAM-1 are differentially expressed on blood-retinal barrier cells during experimental autoimmune uveitis.
Dewispelaere R; Lipski D; Foucart V; Bruyns C; Frère A; Caspers L; Willermain F
Exp Eye Res; 2015 Aug; 137():94-102. PubMed ID: 26093277
[TBL] [Abstract][Full Text] [Related]
39. Ocular immunosuppressive microenvironment and novel drug delivery for control of uveitis.
Teabagy S; Wood E; Bilsbury E; Doherty S; Janardhana P; Lee DJ
Adv Drug Deliv Rev; 2023 Jul; 198():114869. PubMed ID: 37172782
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
